Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...